BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, July 14, 2026
Home
»
Topics
»
Drugs
» Immuno-oncology
Immuno-oncology
RSS
Seattle Genetics and Agensys set to develop additional antibody-drug conjugate
July 3, 2013
MorphoSys and Celgene create alliance to develop MOR-202 for multiple myeloma
July 1, 2013
VivaMab and ADC Therapeutics enter licensing agreement for ADC candidate
July 1, 2013
Japan approves Perjeta for HER2-positive inoperable or recurrent breast cancer
June 28, 2013
EMD Serono creates immune-oncology research and early development platform
June 28, 2013
Phase I study of MORAb-066 commences
June 27, 2013
Preliminary results from phase II trial of DN24-02 in urothelial cancer
June 27, 2013
Prima BioMed to begin three phase II trials of CVac
June 27, 2013
Combinatorial strategies to enhance antitumor efficacy of monoclonal antibodies
June 27, 2013
PsiOxus Therapeutics begins second study of ColoAd1 vaccine
June 21, 2013
Previous
1
2
…
672
673
674
675
676
677
678
679
680
…
1011
1012
Next
RSS